Skip to main content
Modified molecule may treat MS

A molecule engineered more than 20 years ago to reduce cholesterol levels now shows promise as a treatment for multiple sclerosis. The disease causes the body's immune system to attack the myelin sheath surrounding nerves, but experiments with mice show the sobetirome molecule -- recently modified so it can pass the blood-brain barrier -- acts to restore the myelin.

Full Story: